Vytrus Biotech, S.A. (BME:VYT)
Spain
· Delayed Price · Currency is EUR 3.300
0.00 (0.00%)
Last updated: May 13, 2025
Vytrus Biotech Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | 0.7 | 0.54 | 0.61 | 0.45 | 0.22 | - | Upgrade
|
| Depreciation & Amortization | 0.75 | 0.73 | 0.69 | 0.58 | 0.39 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 0.03 | - | Upgrade
|
| Other Operating Activities | -0.3 | -0.09 | 0.08 | -0.7 | -0.62 | - | Upgrade
|
| Change in Accounts Receivable | 0.13 | -0.11 | -0.22 | -0.06 | -0.06 | - | Upgrade
|
| Change in Inventory | 0.02 | -0.14 | -0.16 | -0.04 | -0.06 | - | Upgrade
|
| Change in Accounts Payable | 0.09 | -0.02 | 0.07 | 0.22 | 0.02 | - | Upgrade
|
| Change in Other Net Operating Assets | 0 | -0.01 | -0.05 | 0 | -0.05 | - | Upgrade
|
| Operating Cash Flow | 1.4 | 0.9 | 1.03 | 0.45 | -0.13 | - | Upgrade
|
| Operating Cash Flow Growth | 41.30% | -11.86% | 129.07% | - | - | - | Upgrade
|
| Capital Expenditures | -0.08 | -0.14 | -0.42 | -0.22 | -0.18 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -1 | -1.02 | -0.87 | -0.05 | -0.05 | - | Upgrade
|
| Investment in Securities | 0 | -0.02 | -0.03 | -0.03 | -0 | - | Upgrade
|
| Investing Cash Flow | -1.07 | -1.18 | -1.33 | -0.3 | -0.24 | - | Upgrade
|
| Long-Term Debt Issued | - | 1.65 | 0.38 | 0.27 | 0.86 | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.68 | -0.35 | -0.27 | -0.19 | - | Upgrade
|
| Net Debt Issued (Repaid) | -0.35 | 0.96 | 0.03 | -0.01 | 0.67 | - | Upgrade
|
| Issuance of Common Stock | 1.34 | 0.12 | 0.17 | 0.25 | - | - | Upgrade
|
| Repurchase of Common Stock | -0.26 | -0.42 | -0.46 | -0.2 | -0.03 | - | Upgrade
|
| Financing Cash Flow | 0.77 | 0.66 | -0.26 | 0.05 | 0.64 | - | Upgrade
|
| Net Cash Flow | 1.1 | 0.38 | -0.56 | 0.19 | 0.27 | - | Upgrade
|
| Free Cash Flow | 1.32 | 0.76 | 0.61 | 0.23 | -0.32 | - | Upgrade
|
| Free Cash Flow Growth | 87.45% | 25.94% | 166.43% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 25.15% | 16.22% | 13.51% | 6.47% | -14.15% | - | Upgrade
|
| Free Cash Flow Per Share | 0.17 | 0.11 | - | 0.03 | -0.05 | - | Upgrade
|
| Cash Interest Paid | 0.1 | 0.1 | 0.06 | 0.08 | 0.06 | - | Upgrade
|
| Levered Free Cash Flow | -0.14 | -1.04 | -0.37 | 0.57 | 0.32 | - | Upgrade
|
| Unlevered Free Cash Flow | -0.06 | -0.94 | -0.24 | 0.64 | 0.4 | - | Upgrade
|
| Change in Net Working Capital | 0.13 | 0.76 | 0.02 | -0.08 | -0.11 | -0.09 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.